WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 45.58
-3.82 (-7.73%)
Oct 22, 2026, 2:05 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 187.05 billion as of October 21, 2026. It is the 1,022nd most valuable company in the world and the 48th biggest in Hong Kong. Its market cap has increased by 27.75% in one year.
Market Cap
187.05B
Enterprise Value
182.60B
Revenue
27.27B
Global Rank
Country Rank
#48 Hong Kong
PE Ratio
33.33
ChartMarket Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 187.05B, an increase of 483.82%. That is a compound annual growth rate of 20.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 187.05B | 43.93% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 356.21B |
| Innovent Biologics | 156.77B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.11B |
| Sino Biopharmaceutical | 96.98B |
| Akeso | 88.56B |
| Genscript Biotech | 77.49B |
| RemeGen | 56.84B |
| Biocytogen Pharmaceuticals (Beijing) | 38.77B |